Quantbot Technologies LP Kronos Bio, Inc. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.44 - $3.44 $2,160 - $5,160	-1,500 Reduced 36.63%	2,595 $4,000
Q3 2022 Nov 07, 2022	SELL	$3.35 - $5.55 $29,145 - $48,285	-8,700 Reduced 68.0%	4,095 $13,000
Q2 2022 Aug 09, 2022	BUY	$3.12 - $7.52 $19,032 - $45,872	6,100 Added 91.11%	12,795 $46,000
Q1 2022 May 16, 2022	BUY	$6.26 - $14.42 $25,008 - $57,607	3,995 Added 147.96%	6,695 $48,000
Q4 2021 Feb 11, 2022	BUY	$11.35 - $21.18 $30,645 - $57,186	2,700 New	2,700 $36,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $54.5M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.